Zeke Capital Advisors’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-17,171
Closed -$869K 277
2019
Q4
$869K Sell
17,171
-7,151
-29% -$369K 0.07% 236
2019
Q3
$1.15M Buy
24,322
+19,155
+371% +$874K 0.1% 163
2019
Q2
$243K Sell
5,167
-152
-3% -$7.01K 0.02% 510
2019
Q1
$256K Sell
5,319
-48
-0.9% -$2.4K 0.02% 503
2018
Q4
$239K Buy
+5,367
New +$280K 0.02% 481
2018
Q2
Sell
-9,926
Closed -$622K 645
2018
Q1
$622K Buy
+9,926
New +$681K 0.06% 285
2017
Q4
Sell
-3,786
Closed -$253K 576
2017
Q3
$253K Buy
+3,786
New +$268K 0.03% 362
2017
Q2
Sell
-2,582
Closed -$211K 302
2017
Q1
$211K Buy
+2,582
New +$203K 0.04% 242

Other funds holding CAH

Zeke Capital Advisors's CAH Position: Q1 2020 in Review

Zeke Capital Advisors sold out of Cardinal Health (CAH) in Q1 2020, closing a stake of 17,171 shares — an estimated $869K sold.

Zeke Capital Advisors first reported a position in CAH in Q1 2017 and held it in 8 quarters. The position peaked at $1.15M in Q3 2019. 721 funds tracked by Wall St. Rank hold CAH as of Q1 2020.

  • Zeke Capital Advisors reported no remaining Cardinal Health position as of Q1 2020 after selling out during the quarter.
  • Zeke Capital Advisors sold 17,171 Cardinal Health shares in Q1 2020, an estimated $869K.
  • Zeke Capital Advisors first reported a position in Cardinal Health in Q1 2017 and held it in 8 quarters.
  • Zeke Capital Advisors's Cardinal Health position peaked at $1.15M in Q3 2019.
  • 721 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2020.

Based on Zeke Capital Advisors's 13F filing for Q1 2020, filed 24 Apr 2020.